Blue Lake Biotechnology, Inc. is developing intranasal vaccines that harness the full breadth of the immune system to keep people healthy and prevent serious infectious diseases. Our platform uses a proprietary parainfluenza virus 5 vector into which a foreign gene from a targeted pathogen is inserted. We have generated a robust clinical-stage pipeline of best-in-class vaccines designed to overcome the limitations of existing vaccine technologies. Our lead product candidates have demonstrated potential for high efficacy and durability with few vaccine-related side effects. We aspire to transform the healthcare landscape with better vaccines that are painless, easy to use, and effective.